9
Participants
Start Date
July 31, 2007
Primary Completion Date
March 31, 2011
Study Completion Date
March 31, 2011
saracatinib
Given PO
laboratory biomarker analysis
Correlative studies
Memorial Sloan Kettering Cancer Center, New York
National Cancer Institute (NCI)
NIH